Elizabeth Arden RDEN
-
New Morningstar Analyst Report - Elizabeth Arden , Inc.
… the cosmetics industry is fierce. Elizabeth Arden has been successful in the fragrance ..... it tries to expand into skin care. Elizabeth Arden is still a relatively small player ..... dollars behind fragrance launches. Elizabeth Arden has done a good job of keeping tried …
-
UPDATE 1- Elizabeth Arden's sales miss on N.America weakness
May 3 (Reuters) - Elizabeth Arden Inc's third-quarter sales missed Wall Street forecasts as an overseas sales gain of 6.3 percent was not enough to make up for a more modest 1.7 percent pace in North America.
-
Elizabeth Arden's international sales lead to profits
May 3 (Reuters) - Elizabeth Arden Inc's overseas sales rose 6.3 percent during its fiscal third quarter, helping it to report a profit. But the cosmetics company …
-
Elizabeth Arden ([[ RDEN ]] +2.7%) gains after being upgraded to Outperform on valuation at BMO Capital, citing the company's upcoming brand repositioning with its new Visible Difference line as a ...
Elizabeth Arden ( RDEN +2.7% ) gains after being upgraded to Outperform on valuation at BMO Capital, citing the company's upcoming brand repositioning …
-
TEXT-S&P raises Elizabeth Arden to 'BB-', outlook is stable
March 23 - Overview -- U.S.-based Elizabeth Arden has had positive operating results over the past year ..... We are raising our corporate credit rating on Elizabeth Arden to 'BB-' from 'B+'. -- We are raising the issue …
-
Elizabeth Arden ( RDEN ): FQ2 EPS of $1.42 beats by $0.03. Revenue of $430M (+6% Y/Y) beats by $1M. (PR)
Elizabeth Arden ( RDEN ): FQ2 EPS of $1.42 beats by $0.03 . Revenue of $430M (+6% Y/Y) beats by $1M . ( PR ) Post your comment!
-
Elizabeth Arden Posts Solid Growth in Its Holiday Influenced Second Quarter
Elizabeth Arden RDEN posted fiscal 2012 second-quarter ..... In its December-ending quarter, Elizabeth Arden 's sales expanded roughly 6% on ..... region. Additionally, sales of Elizabeth Arden branded products, which generally …
-
Notable earnings before Thursday's open: [[ACM]], [[ADS]], [[AGN]], [[ALKS]], [[AZN]], [[BCO]], [[BSX]], [[BX]], [[CAH]], [[CAM]], [[CI]], [[CMI]], [[CME]], [[DB]], [[DO]], [[DOW]], [[GR]], [[HOT]], ...
Notable earnings before Thursday's open: ACM , ADS , AGN , ALKS , AZN , BCO , BSX , BX , CAH , CAM , CI , CMI , CME , DB , DO , DOW , GR , HOT , IP , K , LEA , MA , MD , MDC , MRK , MSCI , NOV , NUS , NYT , PHM , PTEN , RCL , RDEN , RGLD , ROP , SBH , SE , SLE , SNE , SXC , TE , TEN , VIAB, WBC , ...
-
Elizabeth Arden Under Review
We are placing Elizabeth Arden RDEN under review as we reassess our operating assumptions for the firm.
-
UPDATE 4-Estee outlook surpasses Street view, shares soar
* Estee shares up over 17 pct, Elizabeth Arden up 0.3 pct